Compare PCRX & PSIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | PSIX |
|---|---|---|
| Founded | 2006 | 1985 |
| Country | United States | United States |
| Employees | N/A | 1000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 999.0M | 929.2M |
| IPO Year | 2010 | N/A |
| Metric | PCRX | PSIX |
|---|---|---|
| Price | $25.41 | $41.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $30.25 | ★ $99.95 |
| AVG Volume (30 Days) | ★ 642.3K | 515.9K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | ★ $541,533,000.00 | N/A |
| Revenue This Year | $6.78 | $24.73 |
| Revenue Next Year | $8.54 | $16.20 |
| P/E Ratio | $131.68 | ★ $17.20 |
| Revenue Growth | ★ 26.04 | N/A |
| 52 Week Low | $18.80 | $25.28 |
| 52 Week High | $27.66 | $119.16 |
| Indicator | PCRX | PSIX |
|---|---|---|
| Relative Strength Index (RSI) | 44.73 | 64.19 |
| Support Level | $24.61 | $36.18 |
| Resistance Level | $26.94 | $43.75 |
| Average True Range (ATR) | 1.00 | 2.37 |
| MACD | -0.25 | 1.37 |
| Stochastic Oscillator | 18.84 | 92.78 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Power Solutions International Inc is an America-based company that manufactures, distributes, and services power systems that run on nondiesel fuels, including natural gas, propane, and gasoline. The company's products are designed to meet emission standards imposed by environmental regulatory bodies like the Environmental Protection Agency. Its products are distributed to a wide range of industrial original equipment manufacturers that supply equipment to sectors including power generation, oil and gas, material handling, airport ground support, agricultural, turf, construction and irrigation. The company generates majority of its sales from United States, and also has its presence in North America (outside of United States), Pacific Rim, Europe and Others.